Join to View Full Profile
370 w 9th aveColumbus, OH 43210
Dr. Lordo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- MD/PhD student at the Ohio State University. Academic and clinical interests in innate immune cell development in acute leukemias and hematopathology.
Education & Training
Ohio State University College of MedicineClass of 2025
Publications & Presentations
PubMed
- 1 citationsEffects of epigenetic therapy on natural killer cell function and development in hematologic malignancy.Matthew R Lordo, Andrew R Stiff, Christopher C Oakes, Bethany L Mundy-Bosse
Journal of Leukocyte Biology. 2023-05-02 - 17 citationsSingle-cell RNA sequencing identifies a population of human liver-type ILC1s.Benjamin Krämer, Ansel P Nalin, Feiyang Ma, Sarah Eickhoff, Philipp Lutz
Cell Reports. 2023-01-31 - 2 citationsAdipocyte CD1d Gene Transfer Induces T Cell Expansion and Adipocyte Inflammation in CD1d Knockout Mice.Run Xiao, Anthony G Mansour, Wei Huang, Quais N Hassan 2nd, Ryan K Wilkins
Journal of Immunology. 2022-05-01
Grant Support
- Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid LeukemiaOHIO STATE UNIVERSITY2022–2025
- Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid LeukemiaOHIO STATE UNIVERSITY2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
